Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15078 | 732 | 34.6 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
66 | 3 | LEPTIN//ADIPONECTIN//ENDOCRINOLOGY & METABOLISM | 84415 |
1300 | 2 | THIAZOLIDINEDIONES//PPAR GAMMA//ROSIGLITAZONE | 8578 |
15078 | 1 | TROGLITAZONE//JTT 501//CS 045 | 732 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TROGLITAZONE | authKW | 961954 | 14% | 22% | 105 |
2 | JTT 501 | authKW | 375422 | 1% | 100% | 9 |
3 | CS 045 | authKW | 296628 | 1% | 89% | 8 |
4 | THIAZOLIDINEDIONES | authKW | 292389 | 13% | 7% | 96 |
5 | CAS 97322 87 7 | authKW | 214525 | 1% | 86% | 6 |
6 | LOBEGLITAZONE | authKW | 130351 | 1% | 63% | 5 |
7 | CLIN PHARMACOKINET DYNAM | address | 125141 | 0% | 100% | 3 |
8 | HQL 975 | authKW | 125141 | 0% | 100% | 3 |
9 | ISOXAZOLIDINEDIONE | authKW | 111234 | 1% | 67% | 4 |
10 | 5 ARYLIDENE 2 4 THIAZOLIDINEDIONES | authKW | 93854 | 0% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 3110 | 26% | 0% | 188 |
2 | Chemistry, Medicinal | 2707 | 18% | 0% | 135 |
3 | Pharmacology & Pharmacy | 2385 | 34% | 0% | 251 |
4 | Toxicology | 380 | 8% | 0% | 55 |
5 | Chemistry, Organic | 72 | 6% | 0% | 45 |
6 | Medicine, Research & Experimental | 44 | 4% | 0% | 30 |
7 | Chemistry, Multidisciplinary | 37 | 8% | 0% | 57 |
8 | Medicine, General & Internal | 20 | 4% | 0% | 31 |
9 | Chemistry, Analytical | 13 | 3% | 0% | 25 |
10 | Biochemical Research Methods | 7 | 2% | 0% | 15 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN PHARMACOKINET DYNAM | 125141 | 0% | 100% | 3 |
2 | MED STAT BIOMETAB | 83427 | 0% | 100% | 2 |
3 | UPJOHN S METAB DIS | 83427 | 0% | 100% | 2 |
4 | HIGH QUAL LIFE S | 66737 | 1% | 40% | 4 |
5 | 1785 JUSOHONMACHI 2 CHOME | 55617 | 0% | 67% | 2 |
6 | UMR INSERM U991 | 55617 | 0% | 67% | 2 |
7 | 1785 JUSOHOMMACHI 2 CHOME | 41714 | 0% | 100% | 1 |
8 | ADV SCI TECHNOL 306 | 41714 | 0% | 100% | 1 |
9 | CARDIOVASC UROGENITAL INVEST BIOL PROD SUPPORT | 41714 | 0% | 100% | 1 |
10 | CENT JUSOHONMACHI 2CHOME YODAGAWA KU | 41714 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | METABOLISM-CLINICAL AND EXPERIMENTAL | 6418 | 5% | 0% | 37 |
2 | DIABETES | 3522 | 4% | 0% | 32 |
3 | MEDICINAL CHEMISTRY RESEARCH | 2199 | 2% | 0% | 13 |
4 | ENDOCRINOLOGY AND METABOLISM | 2108 | 0% | 3% | 2 |
5 | ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 1969 | 1% | 0% | 10 |
6 | DIABETES OBESITY & METABOLISM | 1878 | 1% | 0% | 10 |
7 | DRUG METABOLISM AND DISPOSITION | 1774 | 2% | 0% | 18 |
8 | DIABETOLOGIA | 1428 | 2% | 0% | 17 |
9 | JOURNAL OF MEDICINAL CHEMISTRY | 1084 | 3% | 0% | 24 |
10 | XENOBIOTICA | 1061 | 1% | 0% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TROGLITAZONE | 961954 | 14% | 22% | 105 | Search TROGLITAZONE | Search TROGLITAZONE |
2 | JTT 501 | 375422 | 1% | 100% | 9 | Search JTT+501 | Search JTT+501 |
3 | CS 045 | 296628 | 1% | 89% | 8 | Search CS+045 | Search CS+045 |
4 | THIAZOLIDINEDIONES | 292389 | 13% | 7% | 96 | Search THIAZOLIDINEDIONES | Search THIAZOLIDINEDIONES |
5 | CAS 97322 87 7 | 214525 | 1% | 86% | 6 | Search CAS+97322+87+7 | Search CAS+97322+87+7 |
6 | LOBEGLITAZONE | 130351 | 1% | 63% | 5 | Search LOBEGLITAZONE | Search LOBEGLITAZONE |
7 | HQL 975 | 125141 | 0% | 100% | 3 | Search HQL+975 | Search HQL+975 |
8 | ISOXAZOLIDINEDIONE | 111234 | 1% | 67% | 4 | Search ISOXAZOLIDINEDIONE | Search ISOXAZOLIDINEDIONE |
9 | 5 ARYLIDENE 2 4 THIAZOLIDINEDIONES | 93854 | 0% | 75% | 3 | Search 5+ARYLIDENE+2+4+THIAZOLIDINEDIONES | Search 5+ARYLIDENE+2+4+THIAZOLIDINEDIONES |
10 | 2 4 THIAZOLIDINEDIONE | 92898 | 1% | 32% | 7 | Search 2+4+THIAZOLIDINEDIONE | Search 2+4+THIAZOLIDINEDIONE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HULIN, B , MCCARTHY, PA , GIBBS, EM , (1996) THE GLITAZONE FAMILY OF ANTIDIABETIC AGENTS.CURRENT PHARMACEUTICAL DESIGN. VOL. 2. ISSUE 1. P. 85 -102 | 53 | 79% | 94 |
2 | ORTIZ, A , SANSINENEA, E , (2011) SYNTHETIC THIAZOLIDINEDIONES: POTENTIAL ANTIDIABETIC COMPOUNDS.CURRENT ORGANIC CHEMISTRY. VOL. 15. ISSUE 1. P. 108-127 | 44 | 67% | 3 |
3 | DAY, C , (1999) THIAZOLIDINEDIONES: A NEW CLASS OF ANTIDIABETIC DRUGS.DIABETIC MEDICINE. VOL. 16. ISSUE 3. P. 179 -192 | 55 | 51% | 277 |
4 | SALTIEL, AR , OLEFSKY, JM , (1996) THIAZOLIDINEDIONES IN THE TREATMENT OF INSULIN RESISTANCE AND TYPE II DIABETES.DIABETES. VOL. 45. ISSUE 12. P. 1661-1669 | 25 | 61% | 812 |
5 | PLOSKER, GL , FAULDS, D , (1999) TROGLITAZONE - A REVIEW OF ITS USE IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS.DRUGS. VOL. 57. ISSUE 3. P. 409 -438 | 46 | 51% | 73 |
6 | SCHEEN, AJ , LEFEBVRE, PJ , (1999) TROGLITAZONE: ANTIHYPERGLYCEMIC ACTIVITY AND POTENTIAL ROLE IN THE TREATMENT OF TYPE 2 DIABETES.DIABETES CARE. VOL. 22. ISSUE 9. P. 1568 -1577 | 38 | 58% | 51 |
7 | FURNSINN, C , WALDHAUSL, W , (2002) THIAZOLIDINEDIONES: METABOLIC ACTIONS IN VITRO.DIABETOLOGIA. VOL. 45. ISSUE 9. P. 1211-1223 | 52 | 37% | 53 |
8 | HENRY, RR , (1997) THIAZOLIDINEDIONES.ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. VOL. 26. ISSUE 3. P. 553-& | 29 | 67% | 157 |
9 | PARKER, JC , (2002) TROGLITAZONE: THE DISCOVERY AND DEVELOPMENT OF A NOVEL THERAPY FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 54. ISSUE 9. P. 1173-1197 | 53 | 35% | 48 |
10 | FUJIWARA, T , HORIKOSHI, H , (2000) TROGLITAZONE AND RELATED COMPOUNDS - THERAPEUTIC POTENTIAL BEYOND DIABETES.LIFE SCIENCES. VOL. 67. ISSUE 20. P. 2405 -2416 | 49 | 39% | 52 |
Classes with closest relation at Level 1 |